Cleared Traditional

K151986 - ADVA Centaur Testosterone II (TSTII)

K151986 is the FDA 510(k) clearance for ADVA Centaur Testosterone II (TSTII) by Siemens Healthcare Diagnostics, Inc.. It is a Class 1 Chemistry device (product code CDZ) cleared through the Traditional 510(k) pathway after a 348-day FDA review.

K151986 · Siemens Healthcare Diagnostics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2016
Decision
348d
Days
Class 1
Risk

K151986 is an FDA 510(k) clearance for the ADVA Centaur Testosterone II (TSTII), ADVA Centaur Testosterone II (TSTII) Ma.... Classified as Radioimmunoassay, Testosterones And Dihydrotestosterone (product code CDZ), Class I - General Controls.

Submitted by Siemens Healthcare Diagnostics, Inc. (Tarrytown, US). The FDA issued a Cleared decision on June 29, 2016 after a review of 348 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1680 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Siemens Healthcare Diagnostics, Inc. devices

Submission Details

510(k) Number K151986 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 17, 2015
Decision Date June 29, 2016
Days to Decision 348 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
260d slower than avg
Panel avg: 88d · This submission: 348d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1680
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone

All 53
Devices cleared under the same product code (CDZ) and FDA review panel - the closest regulatory comparables to K151986.
IDS SHBG
K190121 · Immunodiagnostic Systems , Ltd. · Jun 2019
FastPack IP Sex Hormone Binding Globulin Immunoassay
K182521 · Qualigen, Inc. · Jan 2019
Free Testosterone AccuBind ELISA Test System
K181017 · Monobind, Inc. · Jul 2018
Dimension Vista LOCI Total Testosterone Flex reagent cartridge, Dimension Vista Testosterone Calibrator
K151529 · Siemens Healthcare Diagnostics, Inc. · Feb 2016
ARCHITECT 2nd Generation Testosterone
K152155 · Abbott Laboratories · Dec 2015
ADVIA CENTAUR TESTOSTERONE (TSTO)
K133491 · Siemens Healthcare Diagnostics, Inc. · Feb 2014